SQI Diagnostics 

$0.01
2
+$0+14.62% Wednesday 20:06

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

24MayExpected
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
Q4 2022
Q1 2023
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-232.21%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
5.89MRevenue
-13.69MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SQIDF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers diagnostic solutions including assays and instruments, directly competing in the medical diagnostics field.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides a range of diagnostic and research tools that overlap with SQI Diagnostics' offerings in immunodiagnostics.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its subsidiaries, develops technologies for diagnostics, which competes with SQI's diagnostic technologies.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers clinical diagnostics products that compete in the same space as SQI Diagnostics' immunodiagnostic solutions.
QuidelOrtho
QDEL
Mkt Cap1.83B
Quidel Corporation specializes in diagnostic healthcare products similar to SQI Diagnostics, particularly in the areas of infectious disease testing.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics and medical imaging systems that serve similar markets as SQI Diagnostics, particularly in clinical diagnostics.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics is a provider of diagnostic information services, directly competing with SQI Diagnostics in the healthcare diagnostics market.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America provides comprehensive clinical laboratory services, competing with SQI Diagnostics in laboratory testing services.
Resmed
RMD
Mkt Cap36.04B
ResMed Inc. develops medical devices and cloud-based software applications that indirectly compete with SQI Diagnostics in providing healthcare solutions.

About

Medical/Nursing Services
Health Services
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, the company offers microarray instruments for antibody testing workflow. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.
Show more...
CEO
Country
CA
ISIN
CA78466B1085

Listings

0 Comments

Share your thoughts

FAQ

What is SQI Diagnostics stock price today?
The current price of SQIDF is $0.01 USD — it has increased by +14.62% in the past 24 hours. Watch SQI Diagnostics stock price performance more closely on the chart.
What is SQI Diagnostics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange SQI Diagnostics stocks are traded under the ticker SQIDF.
What is SQI Diagnostics revenue for the last year?
SQI Diagnostics revenue for the last year amounts to 5.89M USD.
What is SQI Diagnostics net income for the last year?
SQIDF net income for the last year is -13.69M USD.
In which sector is SQI Diagnostics located?
SQI Diagnostics operates in the Manufacturing sector.
When did SQI Diagnostics complete a stock split?
SQI Diagnostics has not had any recent stock splits.